References: Antibiotic choice for urinary tract infection (UTI) in adults

Australian Commission on Safety and Quality in Health Care (ACSQHC). AURA 2023: Fifth Australian report on antimicrobial use and resistance in human health. Sydney: Australian Commission on Safety and Quality in Health Care (ACSQHC),; 2023. Updated 16 Nov 2023. Accessed 16 Nov 2023. https://www.safetyandquality.gov.au/our-work/antimicrobial-resistance/antimicrobial-use-and-resistance-australia-aura/aura-2023-fifth-australian-report-antimicrobial-use-and-resistance-human-health
Australian Group on Antimicrobial Resistance (AGAR). Australian Gram-negative Surveillance Outcome Program (GnSOP) Bloodstream Infection Annual Report 2023. 2024. https://agargroup.org.au/agar-reports/
Bonkat G, Bartoletti R, Bruyère F, Cai T, Geerlings SE, Köves B, et al. EAU Guidelines on Urological Infections. Arnhem, NL: European Association of Urology; 2024. https://uroweb.org/guidelines/urological-infections
Bowyer L, Robinson HL, Barrett H, Crozier TM, Giles M, Idel I, et al. SOMANZ guidelines for the investigation and management sepsis in pregnancy. Aust N Z J Obstet Gynaecol 2017;57(5):540-51. https://www.ncbi.nlm.nih.gov/pubmed/28670748
Bryce A, Hay AD, Lane IF, Thornton HV, Wootton M, Costelloe C. Global prevalence of antibiotic resistance in paediatric urinary tract infections caused by Escherichia coli and association with routine use of antibiotics in primary care: systematic review and meta-analysis. BMJ 2016;352:i939. https://pubmed.ncbi.nlm.nih.gov/26980184/
CDC. Antibiotic Resistance Threats in the United States, 2019. Atlanta, GA: U.S. Department of Health and Human Services; 2019. https://www.cdc.gov/DrugResistance/Biggest-Threats.htm
Chu CM, Lowder JL. Diagnosis and treatment of urinary tract infections across age groups. Am J Obstet Gynecol 2018;219(1):40-51. https://www.ncbi.nlm.nih.gov/pubmed/29305250
Duffy MA, Hernandez-Santiago V, Orange G, Davey PG, Guthrie B. Trimethoprim prescription and subsequent resistance in childhood urinary infection: multilevel modelling analysis. Br J Gen Pract 2013;63(609):e238-43. https://www.ncbi.nlm.nih.gov/pubmed/23540479
Hall J, Adams NH, Bartlett L, Seale AC, Lamagni T, Bianchi-Jassir F, et al. Maternal Disease With Group B Streptococcus and Serotype Distribution Worldwide: Systematic Review and Meta-analyses. Clin Infect Dis 2017;65(suppl_2):S112-S24. https://www.ncbi.nlm.nih.gov/pubmed/29117328
Hooton TM, Roberts PL, Cox ME, Stapleton AE. Voided midstream urine culture and acute cystitis in premenopausal women. N Engl J Med 2013;369(20):1883-91. http://www.ncbi.nlm.nih.gov/pubmed/24224622
Osthoff M, McGuinness SL, Wagen AZ, Eisen DP. Urinary tract infections due to extended-spectrum beta-lactamase-producing Gram-negative bacteria: identification of risk factors and outcome predictors in an Australian tertiary referral hospital. Int J Infect Dis 2015;34:79-83. https://pubmed.ncbi.nlm.nih.gov/25769526/
Schafer R, Phillippi JC. Group B Streptococcal Bacteriuria in Pregnancy: An Evidence-Based, Patient-Centered Approach to Care. J Midwifery Womens Health 2020;65(3):376-81. https://www.ncbi.nlm.nih.gov/pubmed/32096338
Steinke DT, Seaton RA, Phillips G, MacDonald TM, Davey PG. Prior trimethoprim use and trimethoprim-resistant urinary tract infection: a nested case-control study with multivariate analysis for other risk factors. J Antimicrob Chemother 2001;47(6):781-7. https://pubmed.ncbi.nlm.nih.gov/11389110/
The American College of Obstetricians and Gynaecologists (ACOG). Urinary Tract Infections in Pregnant Individuals. Obstet Gynecol 2023;142(2):435-45. https://www.ncbi.nlm.nih.gov/pubmed/37473414
van Nieuwkoop C, van der Starre WE, Stalenhoef JE, van Aartrijk AM, van der Reijden TJ, Vollaard AM, et al. Treatment duration of febrile urinary tract infection: a pragmatic randomized, double-blind, placebo-controlled non-inferiority trial in men and women. BMC Med 2017;15(1):70. https://www.ncbi.nlm.nih.gov/pubmed/28366170